Use Able AI chat for product recommendations

NY-ESO-1 Polyclonal antibody

NY-ESO-1 Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, IF/ICC, IP, ELISA

CTAG1A, Autoimmunogenic cancer/testis antigen NY-ESO-1, CTAG, CTAG1, ESO1

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for NY-ESO-1 in ?

Tested Applications

Positive WB detected inNCI-H1299 cells, human testis tissue, HT-1080 cells
Positive IP detected inHepG2 cells
Positive IHC detected inhuman lung cancer tissue, human stomach cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHT-1080 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

19521-1-AP targets NY-ESO-1 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

Peptide

Predict reactive species
Full Name cancer/testis antigen 1A
Calculated Molecular Weight 18 kDa
Observed Molecular Weight 16-25 kDa
GenBank Accession NumberNM_139250
Gene Symbol NY-ESO-1
Gene ID (NCBI) 246100
RRIDAB_10638144
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDP78358
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

CTAG1A, also named as NY-ESO-1, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, CTAG1B, LAGE2B and CT6.1, belongs to the CTAG family.

Protocols

Product Specific Protocols
IF protocol for NY-ESO-1 antibody 19521-1-APDownload protocol
IHC protocol for NY-ESO-1 antibody 19521-1-APDownload protocol
IP protocol for NY-ESO-1 antibody 19521-1-APDownload protocol
WB protocol for NY-ESO-1 antibody 19521-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The NY-ESO-1 Polyclonal antibody (Cat# 19521-1-AP) has 4 citations. They appear in Signal Transduction and Targeted Therapy, Nature Cancer, Cell Death & Disease, and Cancer Immunology Research. The research fields span tumor cell metastasis via extracellular vesicles, macrophage polarization in breast cancer, STING-mediated T cell cytotoxicity against cancer cells, and CD8+ T cell–dependent tumor microenvironment remodeling to overcome chemoresistance. All citations used the antibody in human samples, primarily for Western blot and immunofluorescence applications.

SpeciesApplicationTitle
humanWB

Signal Transduct Target Ther

Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis

Authors - Chuan Yang
humanWB

Nat Cancer

The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancer.

Authors - Jiang Liu
humanWB,IF

Cell Death Dis

STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells

Authors - Ling Wang
humanWB

Cancer Immunol Res

CD8+ T cell-Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance

Authors - Liyan Lao
Loading...
||
New chat

Able®

正在加载,请稍候...